Your browser doesn't support javascript.
loading
Risk factors and outcomes in children with high-risk B-cell precursor and T-cell relapsed acute lymphoblastic leukaemia: combined analysis of ALLR3 and ALL-REZ BFM 2002 clinical trials.
Eckert, Cornelia; Parker, Catriona; Moorman, Anthony V; Irving, Julie Ae; Kirschner-Schwabe, Renate; Groeneveld-Krentz, Stefanie; Révész, Tamas; Hoogerbrugge, Peter; Hancock, Jeremy; Sutton, Rosemary; Henze, Guenter; Chen-Santel, Christiane; Attarbaschi, Andishe; Bourquin, Jean-Pierre; Sramkova, Lucie; Zimmermann, Martin; Krishnan, Shekhar; von Stackelberg, Arend; Saha, Vaskar.
Afiliación
  • Eckert C; Department of Pediatric Oncology Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany; German Cancer Consortium, and German Cancer Research Center, Im Neuenheimer Feld, Heidelberg, Germany. Electronic address: cornelia.eckert@charite.de.
  • Parker C; Children's Cancer Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, UK.
  • Moorman AV; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Irving JA; Wolfson Childhood Cancer Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
  • Kirschner-Schwabe R; Department of Pediatric Oncology Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany; German Cancer Consortium, and German Cancer Research Center, Im Neuenheimer Feld, Heidelberg, Germany.
  • Groeneveld-Krentz S; Department of Pediatric Oncology Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Révész T; Department of Hematology-Oncology, SA Pathology at Women's and Children's Hospital and University of Adelaide, Adelaide, Australia.
  • Hoogerbrugge P; Princess Maxima Center for Pediatric Oncology, Utrecht, and Dutch Childhood Oncology Group, Utrecht, the Netherlands.
  • Hancock J; Southmead Hospital Bristol Genetics Laboratory, Bristol, UK.
  • Sutton R; Children's Cancer Institute, School of Women's and Children's Health, University of New South Wales, Sydney, Australia.
  • Henze G; Department of Pediatric Oncology Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Chen-Santel C; Department of Pediatric Oncology Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany; University Children's Hospital, University Medical Center Rostock, Rostock, Germany.
  • Attarbaschi A; St Anna Children's Research Institute and Children's Hospital, Medical University of Vienna, Vienna, Austria.
  • Bourquin JP; Department of Pediatric Oncology, University Children's Hospital, Zurich, Switzerland.
  • Sramkova L; Department of Pediatric Hematology and Oncology, Charles University, 2nd Medical School and University Hospital Motol, Prague, Czech Republic.
  • Zimmermann M; Department of Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
  • Krishnan S; Children's Cancer Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, UK; Tata Translational Cancer Research Centre, Tata Medical Center, New Town, Kolkata, India.
  • von Stackelberg A; Department of Pediatric Oncology Hematology, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Saha V; Children's Cancer Group, Division of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, UK; Tata Translational Cancer Research Centre, Tata Medical Center, New Town, Kolkata, India. Electronic
Eur J Cancer ; 151: 175-189, 2021 07.
Article en En | MEDLINE | ID: mdl-34010787
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre Hematopoyéticas / Leucemia-Linfoma Linfoblástico de Células T Precursoras Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Eur J Cancer Año: 2021 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia-Linfoma Linfoblástico de Células Precursoras B / Protocolos de Quimioterapia Combinada Antineoplásica / Trasplante de Células Madre Hematopoyéticas / Leucemia-Linfoma Linfoblástico de Células T Precursoras Tipo de estudio: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Male Idioma: En Revista: Eur J Cancer Año: 2021 Tipo del documento: Article